Our Mission
Axonis Therapeutics is advancing breakthrough drug discoveries to develop first-in-class therapies for currently incurable neurological disorders, in order to make a real difference for patients, their families, and the global healthcare system.
Scientific Advisory Board
YVES DE KONINCK, Ph.D.
Chair of Scientific Advisory Board
COREY GOODMAN, Ph.D.
Executive Chairman, Co-Founder & Scientific Advisor
ZHIGANG HE, Ph.D.
Scientific Advisor, KCC2 Neurobiology
CLIFFORD WOOLF, Ph.D.
Scientific Advisor, Pain
JACQUELINE FRENCH, M.D.
Scientific Advisor, Clinical Epilepsy
ROGER PORTER, M.D.
Scientific Advisor, Epilepsy & Clinical Pharmacology
LISA MCKERRACHER, Ph.D.
Scientific Advisor & Co-Founder
JAMES GUEST, M.D., Ph.D., FACS
Scientific Advisor, Clinical Spinal Cord Injury